Breast cancer: from pathophysiology to novel therapeutic approaches 2.0
A Zannetti - International Journal of Molecular Sciences, 2023 - mdpi.com
Breast cancer (BC) is the most common malignancy in women worldwide. It is a very
heterogeneous disease characterized by different molecular profiles that are clinically …
heterogeneous disease characterized by different molecular profiles that are clinically …
Harnessing the synergistic potential of NK1R antagonists and selective COX-2 inhibitors for simultaneous targeting of TNBC cells and cancer stem cells
MT Singh, P Thaggikuppe Krishnamurthy… - Journal of Drug …, 2024 - Taylor & Francis
Triple-negative breast cancer (TNBC) lacks the expression of oestrogen receptor (ER),
progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) …
progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) …
[PDF][PDF] Crucial Role of Mitochondrial Mechanisms in the Antineoplastic Effects of Desethylamiodarone
RF HJ - 2023 - pea.lib.pte.hu
Cancer, one of the major health problems in the world, is the second leading cause of death
worldwide following cardiovascular diseases. Approximately 1.9 million new cases and …
worldwide following cardiovascular diseases. Approximately 1.9 million new cases and …